0.80%| Prev Close: | 0.73 |
|---|---|
| Open: | N/A |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | N/A |
| Beta: | N/A |
| Next Earnings Date: | N/A |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 0.45 - 0.92 |
| Volume: | 0 |
| Avg Vol (3m): | 478,118 |
| Market Cap: | N/A |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- MAST THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Tue, Mar 12)
- ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"PR Newswire(Mon, Mar 11)
- Vista Partners Publishes March 2013 Macroeconomic & Investment NewsletterMarketwired(Mon, Mar 4)
- ADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, OthEDGAR Online(Fri, Mar 1)
- ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"PR Newswire(Thu, Feb 28)
- Adventrx To Develop ANX-188 For Complications Of Arterial DiseasePR Newswire(Thu, Feb 28)
- Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success in 2012Marketwired(Thu, Feb 28)
- ADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Tue, Feb 26)
- ADVENTRX Reviews Data Supporting Development Of ANX-188 In New IndicationsPR Newswire(Tue, Feb 26)
- ADVENTRX To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4PR Newswire(Mon, Feb 25)
- 3 Micro-Caps With Sustainable Cash Flowsat Seeking Alpha(Wed, Feb 13)
- 4 Healthcare Stock Stories for Tuesday Wellnessat Wall St. Cheat Sheet(Tue, Feb 12)
- ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188PR Newswire(Mon, Feb 11)
- ADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements andEDGAR Online(Fri, Feb 8)
- Vista Partners Publishes February 2013 Macroeconomic & Investment NewsletterMarketwired(Thu, Feb 7)
Press Releases
- ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"PR Newswire(Mon, Mar 11)
- Vista Partners Publishes March 2013 Macroeconomic & Investment NewsletterMarketwired(Mon, Mar 4)
Reports
- ADVENTRX Pharmaceuticals Inc: Business description, financial summary, 3yr and...Reuters Investment Profile(May 18)
- ValuEngine Industry Report for Medical-drugsValuEngine, Inc.(May 17)
- ValuEngine Industry Report for Mining-miscValuEngine, Inc.(May 17)